Connect directly with engaged patients
Get patient-level insights to help inform strategies for brand-name drugs and help better understand how patients access and afford care.
Direct patient engagement in Pharma programs
Our platform is designed to drive product utilization, which is why we’ve designed it to be so easy to use.
- Capture patient awareness within purchasing journey
- Easy enrollment right from the patient’s phone
Empowering patients through affordability and access
No gatekeeping here — Prescryptive enables patients to compare prices based on pharmacy, availability of manufacturer coupons and application of manufacturer copay assistance.
- Patients can compare prices before purchase
- Local and mail delivery options included
Adherence enhanced through intelligent alerts
Simple tools help solve one of healthcare’s trickiest problems: adherence. Alerts help patients get on and stay on the medications they need.
- Refill alerts to help patients with second fills and more
- Adherence surveys to help you understand why someone stops taking the drug
A strong start to the treatment journey
Patients first encounter our mobile platform at the point of prescribing, quickly understanding how they get their prescriptions and increasing the likelihood of first fills.
- Digital prescriptions accessible from the patient’s phone
- Intelligent alerts help patients find the best prices before purchase
Explore a consumer experience activated by a digital prescription
Patient-level insights
Dashboard shares insights on access, affordability, adherence, outcomes and survey results, leading to data-driven decisions.
News & Insights
2024 round-up: Prescryptive in the news
The best soundbites from our experienced thought leaders.
Understanding the widespread impacts of pharmacy deserts
Pharmacy deserts, perpetuated by multiple factors, have significant implications for patient care and public health. See how Paige…
Change is coming to old pharmacy benefits models – here’s what it can mean for healthcare
The legacy PBM model is no longer sustainable. But the good news is that pharma and other healthcare…
REPORT: Employer attitudes on GLP-1s, including coverage, costs, and outcomes
A recent report by Pharmaceutical Strategies Group (PSG), sponsored by Prescryptive, spotlighted red hot GLP-1s and how employers…
Connect with us
Want to bring transparency to your prescription process? Get in touch to see how.